Mass spectroscopy-based lipidomics and gene expression levels of lipogenic enzymes has indicated that ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) were changed in AML cell lines treated with BaP (Southam et al., 2015). Here, ACACA is linked to acute myeloid leukemia.